Kalmia Latifolia Leaf
Active ingredient
Sold as Joint Tonic R I
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 28
Overview
Plain-language summary, compiled from the cited regulatory records
Kalmia Latifolia Leaf is an active ingredient used for the temporary relief of symptoms associated with joint aches, pains, swelling, and rheumatism [1]. These claims are based on traditional homeopathic practice and have not been evaluated by regulatory bodies [1].
This ingredient is available under various brand names, including Joint Tonic R I [1]. In the past 12 months, there have been 28 adverse event reports associated with products containing Kalmia Latifolia Leaf [2]. The most frequently reported adverse events include eye pain, death, diarrhea, eye irritation, and foreign body sensation in the eyes [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 21, 2026 |
USUnited States· FDA
1 product
Uses
** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
How to take
Sources & citations
- [1]FDA DailyMed · 183e5794-76a4-45… · revised January 21, 2026 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.